LE VALPROMIDE (DEPAMIDE®) DANS LE TRAITEMENT D'ETATS PSYCHOTIQUES AIGUS. UNE ETUDE CLINIQUE OUVERTE

Translated title of the contribution: Valpromide (Depamide®) in the treatment of acute psychotic states: An open clinical study

A. C. Altamura, R. Basile, M. Mauri, C. L. Cazzullo

Research output: Contribution to journalArticle

Abstract

In an open clinical study on the effect of Depamide in acute psychosis, 59 schizophrenic and 23 manic hospitalized patients were tested. They were divided in two groups: in group A, Depamide was administered only after an initial period of treatment with haloperidol or chlorpromazine; in group B instead, Depamide was added from the beginning of the neuroleptic treatment. The results show that the association of Depamide with neuroleptics leads to a reduction of agitation and of the hospitalization period, whereas it ameliorates the adaptation of the patients to the therapeutic milieu.

Translated title of the contributionValpromide (Depamide®) in the treatment of acute psychotic states: An open clinical study
Original languageFrench
Pages (from-to)297-304
Number of pages8
JournalActa Psychiatrica Belgica
Volume86
Issue number3
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Valpromide (Depamide®) in the treatment of acute psychotic states: An open clinical study'. Together they form a unique fingerprint.

  • Cite this